{"classes":[{"categories":[{"measurements":[{"comment":"Here \"NA\" means median and upper limit of 95% CI could not be calculated and estimated as there were insufficient number of participants with events.","groupId":"OG000","lowerLimit":"8.9","upperLimit":"NA","value":"NA"},{"comment":"Here \"NA\" means upper limit of 95% CI could not be calculated and estimated as there were insufficient number of participants with events.","groupId":"OG001","lowerLimit":"10.9","upperLimit":"NA","value":"11.1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"85"}],"units":"Participants"}],"description":"Time to subsequent cancer treatments was defined as the time from randomization to the start for the first new anticancer treatment.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants received 3 cycles of oral solution of Xevinapant at a dose of 200 milligrams per day (mg/day) once daily from Day 1 to 14, per 3-week cycle in combination with 66 Gray (Gy) of intensity modulated radiation therapy (IMRT) in 33 fractions, 2 Gy/fraction, 5 days/week followed by 3 cycles of monotherapy of Xevinapant at a dose of 200 mg/day from Day 1 to 14, per 3-week cycle (Each cycle is of 3 weeks).","id":"OG000","title":"Xevinapant +IMRT"},{"description":"Participants received 3 cycles of oral solution of placebo matched to Xevinapant once daily from Day 1 to 14 per 3-week cycle in combination with with 66 Gray (Gy) of intensity modulated radiation therapy (IMRT) in 33 fractions, 2 Gy/fraction, 5 days/week followed by 3 cycles of monotherapy of placebo matched to Xevinapant from Day 1 to 14, per 3-week cycle (Each cycle is of 3 weeks).","id":"OG001","title":"Placebo +IMRT"}],"paramType":"MEDIAN","populationDescription":"FAS included all participants who were randomized to study treatment.","reportingStatus":"POSTED","timeFrame":"Time from randomization to the start of first subsequent cancer treatment, assessed up to 22.7 months","title":"Time to Subsequent Cancer Treatments","type":"SECONDARY","unitOfMeasure":"months"}